Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109


Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.

Amjad AI, Ali H, Appleman LJ, Maranchie J, Jackman S, Parwani A, Dhir R, Roy S, Parikh RA.

Case Rep Oncol Med. 2014;2014:615895. doi: 10.1155/2014/615895. Epub 2014 Aug 19.


Argument for prostate cancer screening in populations of African-Caribbean origin.

Patrick A, Bunker C, Nelson J, Dhir R, Wheeler V, Zmuda J, Richard JR, Belle A, Kuller L.

BJU Int. 2014 Jul 21. doi: 10.1111/bju.12869. [Epub ahead of print]


Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A.

Am J Surg Pathol. 2013 Dec;37(12):1824-30. doi: 10.1097/PAS.0000000000000108.


Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear?

Roy S, Parwani AV, Dhir R, Yousem SA, Kelly SM, Pantanowitz L.

Am J Clin Pathol. 2013 Sep;140(3):363-9. doi: 10.1309/AJCPHUE5ENZDU4DJ.


Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.

Ai J, Pascal LE, O'Malley KJ, Dar JA, Isharwal S, Qiao Z, Ren B, Rigatti LH, Dhir R, Xiao W, Nelson JB, Wang Z.

Oncogene. 2014 May 1;33(18):2286-94. doi: 10.1038/onc.2013.190. Epub 2013 May 27.


Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.


Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography.

LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, Marroquin OC, Mulukutla SR, McNamara DM.

BMC Med. 2012 Dec 5;10:157. doi: 10.1186/1741-7015-10-157.


Clinical integration of next-generation sequencing technology.

Gullapalli RR, Lyons-Weiler M, Petrosko P, Dhir R, Becich MJ, LaFramboise WA.

Clin Lab Med. 2012 Dec;32(4):585-99. doi: 10.1016/j.cll.2012.07.005. Review.


Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.

Singh SV, Kim SH, Sehrawat A, Arlotti JA, Hahm ER, Sakao K, Beumer JH, Jankowitz RC, Chandra-Kuntal K, Lee J, Powolny AA, Dhir R.

J Natl Cancer Inst. 2012 Aug 22;104(16):1228-39. doi: 10.1093/jnci/djs321. Epub 2012 Aug 2.


Renal cell neoplasms contain shared tumor type-specific copy number variations.

Krill-Burger JM, Lyons MA, Kelly LA, Sciulli CM, Petrosko P, Chandran UR, Kubal MD, Bastacky SI, Parwani AV, Dhir R, LaFramboise WA.

Am J Pathol. 2012 Jun;180(6):2427-39. doi: 10.1016/j.ajpath.2012.01.044. Epub 2012 Apr 3.


Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.

Rubatt JM, Darcy KM, Tian C, Muggia F, Dhir R, Armstrong DK, Bookman MA, Niedernhofer LJ, Deloia J, Birrer M, Krivak TC.

Gynecol Oncol. 2012 May;125(2):421-6. doi: 10.1016/j.ygyno.2012.01.008. Epub 2012 Jan 16.


Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Wu Q, Dhir R, Wells A.

Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3.


Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.

Zhao T, Zeng X, Bateman NW, Sun M, Teng PN, Bigbee WL, Dhir R, Nelson JB, Conrads TP, Hood BL.

J Proteome Res. 2012 Feb 3;11(2):1089-99. doi: 10.1021/pr200829f. Epub 2011 Dec 1.


Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.

Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A.

Cancer Microenviron. 2012 Apr;5(1):19-28. doi: 10.1007/s12307-011-0085-4. Epub 2011 Sep 3.


Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Visus C, Ito D, Dhir R, Szczepanski MJ, Chang YJ, Latimer JJ, Grant SG, DeLeo AB.

Cancer Immunol Immunother. 2011 Jul;60(7):919-29. doi: 10.1007/s00262-011-1001-y. Epub 2011 Mar 16.


Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate.

Tomaszewski JJ, Cummings JL, Parwani AV, Dhir R, Mason JB, Nelson JB, Bacich DJ, O'Keefe DS.

Prostate. 2011 Sep;71(12):1287-93. doi: 10.1002/pros.21346. Epub 2011 Feb 9.


Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.

Teng PN, Hood BL, Sun M, Dhir R, Conrads TP.

J Proteome Res. 2011 Mar 4;10(3):1333-42. doi: 10.1021/pr101074p. Epub 2011 Jan 12.


Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.

Chang G, Xu S, Dhir R, Chandran U, O'Keefe DS, Greenberg NM, Gingrich JR.

Clin Cancer Res. 2010 Nov 15;16(22):5390-401. doi: 10.1158/1078-0432.CCR-10-1461. Epub 2010 Nov 9.


Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.

Stabile LP, Dacic S, Land SR, Lenzner DE, Dhir R, Acquafondata M, Landreneau RJ, Grandis JR, Siegfried JM.

Clin Cancer Res. 2011 Jan 1;17(1):154-64. doi: 10.1158/1078-0432.CCR-10-0992. Epub 2010 Nov 9.


A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research.

Amin W, Singh H, Pople AK, Winters S, Dhir R, Parwani AV, Becich MJ.

J Pathol Inform. 2010 Aug 10;1. pii: 12. doi: 10.4103/2153-3539.68314.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk